Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Urashima, M.
Right arrow Articles by Anderson, K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Urashima, M.
Right arrow Articles by Anderson, K. C.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

p16INK4A Promotes Differentiation and Inhibits Apoptosis of JKB Acute Lymphoblastic Leukemia Cells

Mitsuyoshi Urashima, James A. DeCaprio, Dharminder Chauhan, Gerrard Teoh, Atsushi Ogata, Steven P. Treon, Yasutaka Hoshi, and Kenneth C. Anderson

From the Divisions of Hematologic Malignancies and Neoplastic Disease Mechanisms, Dana-Farber Cancer Institute and the Department of Medicine, Harvard Medical School, Boston, MA; and the Department of Pediatrics, Jikei University School of Medicine, Tokyo, Japan.

Homozygous p16INK4A (p16) gene deletion is frequent in primary tumor cells from acute lymphoblastic leukemia (ALL), suggesting that loss of p16 may be an important precursor to transformation in ALL. We have previously described JKB, a human ALL cell line, that contains homozygous deletion of the p16 gene. Because ectopic expression of p16 suppresses cell growth, we created a temperature sensitive p16 mutant to develop a system for inducible p16 function in human ALL. JKB cells were transfected either with a p16 gene mutated at position 119 (E119G) to confer temperature sensitivity (JKB p16MT) or with control vector. The percentage of cells in G1 phase was similar in JKB control cells or in JKB p16MT cells cultured at restrictive conditions (40°C). However, with lowering of temperature from 40°C to permissive conditions (31°C), the percentage of JKB p16MT cells in G1 phase and binding of p16 to CDK4 and CDK6 increased, with associated decreases in CDK4 and CDK6 kinase activities, and dephosphorylation of retinoblastoma protein (pRB). Culture of JKB p16MT cells at 31°C for >= 3 days irreversibly inhibited growth. Moreover, JKB p16MT cells cultured under these permissive conditions showed a less transformed morphology and more differentiated phenotype than did these cells cultured under restrictive temperatures. Finally, dexamethasone (Dex) induced apoptosis of JKB p16MT cells cultured at 40°C, but did not trigger death of these cells cultured at 31°C. These results suggest that deletion of p16 gene in JKB human ALL cells is associated with dysregulated growth of less differentiated tumor cells, which nonetheless remain susceptible to apoptosis triggered by Dex.

Blood, Vol. 90 No. 10 (November 15), 1997: pp. 4106-4115
© 1997 by The American Society of Hematology.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. U. Barbie, D. A. Barbie, D. T. MacLaughlin, S. Maheswaran, and P. K. Donahoe
Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107
PNAS, December 23, 2003; 100(26): 15601 - 15606.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
T. Plath, M. Peters, K. Detjen, M. Welzel, Z. von Marschall, C. Radke, B. Wiedenmann, and S. Rosewicz
Overexpression of pRB in Human Pancreatic Carcinoma Cells: Function in Chemotherapy-Induced Apoptosis
J Natl Cancer Inst, January 16, 2002; 94(2): 129 - 142.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Doi, T. Ikeda, H. Itoh, K. Ueyama, K. Hosoda, Y. Ogawa, J. Yamashita, T.-H. Chun, M. Inoue, K. Masatsugu, et al.
C-Type Natriuretic Peptide Induces Redifferentiation of Vascular Smooth Muscle Cells With Accelerated Reendothelialization
Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 930 - 936.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. L. Lewis, W. Chinswangwatanakul, B. Zheng, S. B. Marley, D. X. Nguyen, N. C. P. Cross, L. Banerji, J. Glassford, N. S. B. Thomas, J. M. Goldman, et al.
The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells
Blood, May 1, 2001; 97(9): 2604 - 2610.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. G. Farwell, K. A. Shera, J. I. Koop, G. A. Bonnet, C. P. Matthews, G. W. Reuther, M. D. Coltrera, J. K. McDougall, and A. J. Klingelhutz
Genetic and Epigenetic Changes in Human Epithelial Cells Immortalized by Telomerase
Am. J. Pathol., May 1, 2000; 156(5): 1537 - 1547.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Dobashi, M. Shoji, M. Kitagawa, T. Noguchi, and T. Kameya
Simultaneous Suppression of cdc2 and cdk2 Activities Induces Neuronal Differentiation of PC12 Cells
J. Biol. Chem., April 21, 2000; 275(17): 12572 - 12580.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Omura-Minamisawa, M. B. Diccianni, A. Batova, R. C. Chang, L. J. Bridgeman, J. Yu, J. Pullen, W. P. Bowman, and A. L. Yu
Universal Inactivation of Both p16 and p15 but not Downstream Components Is an Essential Event in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia
Clin. Cancer Res., April 1, 2000; 6(4): 1219 - 1228.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S. J. Frost, D. J. Simpson, R. N. Clayton, and W. E. Farrell
Transfection of an Inducible p16/CDKN2A Construct Mediates Reversible Growth Inhibition and G1 Arrest in the AtT20 Pituitary Tumor Cell Line
Mol. Endocrinol., November 1, 1999; 13(11): 1801 - 1810.
[Abstract] [Full Text]


Home page
BloodHome page
N. Shah, L. Oseth, and T. W. LeBien
Development of a Model for Evaluating the Interaction Between Human Pre-B Acute Lymphoblastic Leukemic Cells and the Bone Marrow Stromal Cell Microenvironment
Blood, November 15, 1998; 92(10): 3817 - 3828.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Urashima, G. Teoh, D. Chauhan, A. Ogata, S. Shirahama, C. Kaihara, M. Matsuzaki, H. Matsushima, M. Akiyama, Y. Yuza, et al.
MDM2 Protein Overexpression Inhibits Apoptosis of TF-1 Granulocyte-Macrophage Colony-Stimulating Factor-Dependent Acute Myeloblastic Leukemia Cells
Blood, August 1, 1998; 92(3): 959 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. U. Ha, D. L. Segev, D. Barbie, P. T. Masiakos, T. T. Tran, D. Dombkowski, M. Glander, T. R. Clarke, H. K. Lorenzo, P. K. Donahoe, et al.
Mullerian Inhibiting Substance Inhibits Ovarian Cell Growth through an Rb-independent Mechanism
J. Biol. Chem., November 17, 2000; 275(47): 37101 - 37109.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 1997 by American Society of Hematology         Online ISSN: 1528-0020